Feb 5, 2019

Poorer countries are falling further behind on cancer outcomes

Expand chart
Data: Institute for Health Metrics and Evaluation; Chart: Harry Stevens/Axios

Between 2007 and 2017, cancer deaths increased from 7.6 million to 9.6 million globally — but the vast majority of that increase was in low- and middle-income countries.

The big picture: In wealthy nations, lower smoking rates, personalized medicine, and novel treatments like immunotherapy are reducing cancer rates and improving survival, even among aging populations. The opposite is true in poorer nations, which saw 80% of the increase, especially in South Asia and sub-Saharan Africa.

What's happening: Population growth and aging are fueling a rise in cancers and noncommunicable diseases in poor countries, which are ill-prepared to handle them.

  • In Bangladesh, for example, the median age increased from 19 to 26 between 1990 and 2015, even as the population grew nearly 50%. As a result, Bangladesh gained 38 million more adults between the ages of 25 and 64.

Where it stands: Such dramatic demographic changes are accelerating a shift from the infectious and nutritional diseases that mostly affect children to cancer and the other noncommunicable diseases that mostly afflict adults. Treating cancers requires more health infrastructure like clinics, labs and hospitals, and skilled workforces to make accurate diagnoses and perform radiotherapy, chemotherapy and surgery.

  • Yes, but: That infrastructure is expensive, far beyond most countries’ health budgets. All 48 governments in sub-Saharan Africa together spent less on health in 2014 ($67 billion) than the government of Australia ($68 billion). Many developing countries cannot keep up with the pace and scale of the health changes in their populations.

The bottom line: Much of the progress being made on cancer is not reaching poor countries. International investment would be needed to improve their health infrastructure, but in the meantime, efforts to increase tobacco controls and vaccinations that prevent cervical cancer could help to slow the global rise of cancer.

Thomas J. Bollyky is senior fellow at the Council on Foreign Relations and the author of “Plagues and the Paradox of Progress: Why the World is Getting Healthier in Worrisome Ways.”

Go deeper

Google develops AI system that outperforms radiologists in detecting breast cancer

Photo: Lyu Liang/VCG via Getty Images

Google Health developed an artificial intelligence system that can identify cases of breast cancer from mammograms more accurately than radiologists according to an international study, the Financial Times reports.

Why it matters: It's the latest example of how AI could improve early detection of diseases and reduce both false positives and false negatives diagnoses.

Go deeperArrowJan 2, 2020

America's heart disease epidemic

Illustration: Aïda Amer/Axios

Americans are increasingly dying of heart disease and strokes as they hit middle age — and the trend is happening across the country, according to a Wall Street Journal analysis of mortality rates.

Why it matters: It suggests "that the underlying causes of cardiovascular disease are universal and difficult to address," the Journal found.

Go deeperArrowJan 14, 2020

Drugmakers opt to mine medical data in lieu of lengthy clinical trials

Big drugmakers Pfizer, Johnson & Johnson and Amgen have submitted data-mining analyses of electronic medical records to the Food and Drug Administration to help expedite the approval of new or improved medicines, the Wall Street Journal reports.

Why it matters: So far, parsing patient data instead of carrying out long clinical trials has cut costs and shortened drug-development times for breast cancer, bladder cancer and leukemia drugs.

Go deeperArrowDec 23, 2019